PARCOPA Side Effects

6286811-9 | Condition Aggravated, Cystitis Interstitial, Product Substitution Issue
on Jul 27, 2009 Female patient from UNITED STATES , 73 years of age, weighting 149.0 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Parcopa (View Usage). Patient experienced the following unwanted or unexpected effects: condition aggravated, cystitis interstitial, product substitution issue. Parcopa dosage: Once Tablet 10x Daily. During the same period patient was treated with MIRAPEX (View Mirapex Review and Mirapex Label ), SELEGILINE ODT (ZELAPAR) (View Selegiline Odt (zelapar) Review and Selegiline Odt (zelapar) Label ).

5948673-6 | Confusional State, Contusion, Fall, Haematoma
Patient was taking Parcopa (View Usage). Patient had the following side effects: confusional state, contusion, fall (What is fall?), haematoma on Oct 22, 2008 from UNITED STATES Additional patient health information: Male patient , 75 years of age, weighting 214.0 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Parcopa dosage: Oral. During the same period patient was treated with COMTAN (View Comtan Review and Comtan Label ). Patient was hospitalized.

5763928-6 | Bone Marrow Failure, Head Injury, Syncope
Adverse event was reported on Jun 06, 2008 by a Male patient taking Parcopa (View Usage) (Dosage: 1 4 Times Daily Po) was diagnosed with parkinsonism, immunodeficiency and. Location: UNITED STATES , 66 years of age, weighting 161.0 lb, After Parcopa was administered, patient had the following side effects: bone marrow failure, head injury, syncope. During the same period patient was treated with BACTRIM DS (1 Daily Po) (View Bactrim Ds Review and Bactrim Ds Label ). Patient was hospitalized.

5097433-X | Abnormal Dreams, Condition Aggravated, Convulsion, Delirium, Delusion, Dyskinesia, Extrapyramidal Disorder, Hallucination, Nightmare
on Aug 25, 2006 Female patient from UNITED STATES , 83 years of age, weighting 80.00 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Parcopa (View Usage). Patient experienced the following unwanted or unexpected effects: abnormal dreams, condition aggravated, convulsion, delirium, delusion, dyskinesia, extrapyramidal disorder, hallucination, nightmare. Parcopa dosage: Oral. During the same period patient was treated with AMANTADINE HCL (See Image) (View Amantadine Hcl Review and Amantadine Hcl Label ), SINEMET (See Image) (View Sinemet Review and Sinemet Label ), PRAMIPEXOLE DIHYDROCHLORIDE (See Image) (View Pramipexole Dihydrochloride Review and Pramipexole Dihydrochloride Label ), ENTACAPONE (200 Mg,4 In 1 D, Oral) (View Entacapone Review and Entacapone Label ). Patient was hospitalized.


5072715-6 | Agranulocytosis, Fluid Overload, Neutrophil Count Decreased, Platelet Count Decreased
on Jul 24, 2006 Female patient from UNITED STATES , 50 years of age, was treated with Parcopa (View Usage). Patient had the following side effects: agranulocytosis, fluid overload, neutrophil count decreased, platelet count decreased. Parcopa dosage: 3 In 1 D, Oral. During the same period patient was treated with CEFTRIAXONE SODIUM (View Ceftriaxone Sodium Review and Ceftriaxone Sodium Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ). Patient was hospitalized.